Glutathione is required for efficient production of infectious picornavirus virions

Virology

Volumn 353, Issue 2, 2006, Pages 258-267

  Smith, Allen D ^a   Dawson, Harry ^a  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Coxsackievirus B3; Glutathione; Picornavirus; Replication

Indexed keywords

BUTHIONINE SULFOXIMINE; CESIUM CHLORIDE; DITHIOTHREITOL; GLUTATHIONE; GLUTATHIONE ETHYL ESTER; MERCAPTOETHANOL; SUCROSE; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS B4; CULTURE MEDIUM; CYTOPATHOGENIC EFFECT; FRACTIONATION; GLUTATHIONE METABOLISM; HELA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN RHINOVIRUS; INFLUENZA VIRUS; NONHUMAN; PICORNAVIRUS; PICORNAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SENDAI VIRUS; VIRION; VIRUS CAPSID; VIRUS CULTURE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION;

ANTIMETABOLITES; BUTHIONINE SULFOXIMINE; GLUTATHIONE; HELA CELLS; HUMANS; PICORNAVIRIDAE; RNA, VIRAL; VIRAL PROTEINS; VIRION; VIRUS REPLICATION;

COXSACKIEVIRUS; HUMAN HERPESVIRUS 1; MIRIDAE; ORTHOMYXOVIRIDAE; PICORNAVIRIDAE; SENDAI VIRUS;

EID: 33748698840     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.06.012     Document Type: Article

References (63)

1. Abate C., Patel L., Rauscher F.J., and Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249 4973 (1990) 1157-1161
2. Agol V.I., Belov G.A., Bienz K., Egger D., Kolesnikova M.S., Raikhlin N.T., Romanova L.I., Smirnova E.A., and Tolskaya E.A. Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis but not cytopathic effect. Virology 252 2 (1998) 343-353
3. Agol V.I., Belov G.A., Bienz K., Egger D., Kolesnikova M.S., Romanova L.I., Sladkova L.V., and Tolskaya E.A. Competing death programs in poliovirus-infected cells: commitment switch in the middle of the infectious cycle. J. Virol. 74 12 (2000) 5534-5541
4. Anderson M.E., Powrie F., Puri R.N., and Meister A. Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione. Arch. Biochem. Biophys. 239 2 (1985) 538-548
5. Baker M.A., Cerniglia G.J., and Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal. Biochem. 190 2 (1990) 360-365
6. Baltimore D., Girard M., and Darnell J.E. Aspects of the synthesis of poliovirus RNA and the formation of virus particles. Virology 29 2 (1966) 179-189
7. Bauer M., and Bauer I. Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress. Antioxid. Redox Signal. 4 5 (2002) 749-758
8. Beck M.A., Kolbeck P.C., Rohr L.H., Shi Q., Morris V.C., and Levander O.A. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice. J. Nutr. 124 3 (1994) 345-358
9. Beck M.A., Shi Q., Morris V.C., and Levander O.A. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1 5 (1995) 433-436
10. Buenz E.J., and Howe C.L. Picornaviruses and cell death. Trends Microbiol. 14 1 (2006) 28-36
11. Cai J., Chen Y., Seth S., Furukawa S., Compans R.W., and Jones D.P. Inhibition of influenza infection by glutathione. Free Radical Biol. Med. 34 7 (2003) 928-936
12. Caliguiri L.A., and Compans R.W. The formation of poliovirus particles in association with the RNA replication complexes. J. Gen. Virol. 21 (1973) 99-108
13. Caliguiri L.A., and Tamm I. Action of guanidine on the replication of poliovirus RNA. Virology 35 3 (1968) 408-417
14. Chapman N.M., Tu Z., Tracy S., and Gauntt C.J. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch. Virol. 135 1-2 (1994) 115-130
15. Chen P.C., Gaetjens E., and Broome J.D. Mercaptoethanol protects glutathione depleted cells. Agents Actions 22 1-2 (1987) 171-175
16. Esposito F., Ammendola R., Faraonio R., Russo T., and Cimino F. Redox control of signal transduction, gene expression and cellular senescence. Neurochem. Res. 29 3 (2004) 617-628
17. Garaci E., Palamara A.T., Ciriolo M.R., D'Agostini C., Abdel-Latif M.S., Aquaro S., Lafavia E., and Rotilio G. Intracellular GSH content and HIV replication in human macrophages. J. Leukocyte Biol. 62 1 (1997) 54-59
18. Garaci E., Palamara A.T., Ciriolo M.R., D'Agostini C., Abdel-Latif M.S., Aquaro S., Lafavia E., Rotilio G., and del-Latif M.S. Intracellular GSH content and HIV replication in human macrophages. J. Leukocyte Biol. 62 1 (1997) 54-59
19. Goldstaub D., Gradi A., Bercovitch Z., Grosmann Z., Nophar Y., Luria S., Sonenberg N., and Kahana C. Poliovirus 2A protease induces apoptotic cell death. Mol. Cell. Biol. 20 4 (2000) 1271-1277
20. Griffith O.W., and Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254 16 (1979) 7558-7560
21. Haddad J.J. Oxygen-sensitive pro-inflammatory cytokines, apoptosis signaling and redox-responsive transcription factors in development and pathophysiology. Cytokines Cell. Mol. Ther. 7 1 (2002) 1-14
22. Hamilos D.L., and Wedner H.J. The role of glutathione in lymphocyte activation: I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. J. Immunol. 135 4 (1985) 2740-2747
23. Hehner S.P., Breitkreutz R., Shubinsky G., Unsoeld H., Schulze-Osthoff K., Schmitz M.L., and Droge W. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J. Immunol. 165 8 (2000) 4319-4328
24. Hellen C.U.T., and Wimmer E. Maturation of poliovirus capsid proteins. In: Robart H.A. (Ed). Human Enterovirus Infections (1995), ASM Press, Washington, D.C. 155-177
25. Henke A., Nestler M., Strunze S., Saluz H.P., Hortschansky P., Menzel B., Martin U., Zell R., Stelzner A., and Munder T. The apoptotic capability of coxsackievirus B3 is influenced by the efficient interaction between the capsid protein VP2 and the proapoptotic host protein Siva. Virology 289 1 (2001) 15-22
26. Herzenberg L., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., and Deresinski S.C. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. U.S.A. 94 5 (1997) 1967-1972
27. Ishii T., Bannai S., and Sugita Y. Mechanism of growth stimulation of L1210 cells by 2-mercaptoethanol in vitro. Role of the mixed disulfide of 2-mercaptoethanol and cysteine. J. Biol. Chem. 256 23 (1981) 12387-12392
28. Jackson A.A., Gibson N.R., Lu Y., and Jahoor F. Synthesis of erythrocyte glutathione in healthy adults consuming the safe amount of dietary protein. Am. J. Clin. Nutr. 80 1 (2004) 101-107
29. Kwon Y.W., Masutani H., Nakamura H., Ishii Y., and Yodoi J. Redox regulation of cell growth and cell death. Biol. Chem. 384 7 (2003) 991-996
30. Kyto V., Lapatto R., Lakkisto P., Saraste A., Voipio-Pulkki L.M., Vuorinen T., and Pulkki K. Glutathione depletion and cardiomyocyte apoptosis in viral myocarditis. Eur. J. Clin. Invest. 34 3 (2004) 167-175
31. Lauriault V.V., and O'Brien P.J. Molecular mechanism for prevention of N-acetyl-p-benzoquinoneimine cytotoxicity by the permeable thiol drugs diethyldithiocarbamate and dithiothreitol. Mol. Pharmacol. 40 1 (1991) 125-134
32. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method. Methods 25 4 (2001) 402-408
33. Lynn D.E. A BASIC computer program for analyzing endpoint assays. Biotechniques 12 6 (1992) 880-881
34. Macchia I., Palamara A.T., Bue C., Savini P., Ciriolo M., Gaziano R., and di Francesco P. Increased replication of Sendai virus in morphine-treated epithelial cells: evidence for the involvement of the intracellular levels of glutathione. Int. J. Immunopharmacol. 21 3 (1999) 185-193
35. Manhart N., Vierlinger K., Spittler A., Bergmeister H., Sautner T., and Roth E. Oral feeding with glutamine prevents lymphocyte and glutathione depletion of Peyer's patches in endotoxemic mice. Ann. Surg. 234 1 (2001) 92-97
36. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
37. Micke P., Beeh K.M., Schlaak J.F., and Buhl R. Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur. J. Clin. Invest. 31 2 (2001) 171-178
38. Mikami T., Satoh N., Hatayama I., and Nakane A. Buthionine sulfoximine inhibits cytopathic effect and apoptosis induced by infection with human echovirus 9. Arch. Virol. 149 6 (2004) 1117-1128
39. Miller L.T., Watson W.H., Kirlin W.G., Ziegler T.R., and Jones D.P. Oxidation of the glutathione/glutathione disulfide redox state is induced by cysteine deficiency in human colon carcinoma HT29 cells. J. Nutr. 132 8 (2002) 2303-2306
40. Minor P.D. Growth, assay and purification of picornaviruses. In: Mahy B. (Ed). Virology: A Practical Approach (1985), IRL Press, Oxford, Washington DC 25-41
41. Nelson H.K., Shi Q., Van Dael P., Schiffrin E.J., Blum S., Barclay D., Levander O.A., and Beck M.A. Host nutritional selenium status as a driving force for influenza virus mutations. FASEB J. 15 10 (2001) 1846-1848
42. Nencioni L., Iuvara A., Aquilano K., Ciriolo M.R., Cozzolino F., Rotilio G., Garaci E., and Palamara A.T. Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2. FASEB J. 17 6 (2003) 758-760
43. Palamara A.T., Perno C.F., Ciriolo M.R., Dini L., Balestra E., D'Agostini C., Di Francesco P., Favalli C., Rotilio G., and Garaci E. Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication. Antiviral Res. 27 3 (1995) 237-253
44. Pani G., Colavitti R., Borrello S., and Galeotti T. Redox regulation of lymphocyte signaling. IUBMB Life 49 5 (2000) 381-389
45. Rasilainen S., Ylipaasto P., Roivainen M., Bouwens L., Lapatto R., Hovi T., and Otonkoski T. Mechanisms of beta cell death during restricted and unrestricted enterovirus infection. J. Med. Virol. 72 3 (2004) 451-461
46. Roberts J.C., and Francetic D.J. The importance of sample preparation and storage in glutathione analysis. Anal. Biochem. 211 2 (1993) 183-187
47. Romanova L.I., Belov G.A., Lidsky P.V., Tolskaya E.A., Kolesnikova M.S., Evstafieva A.G., Vartapetian A.B., Egger D., Bienz K., and Agol V.I. Variability in apoptotic response to poliovirus infection. Virology 331 2 (2005) 292-306
48. Roth E., Oehler R., Manhart N., Exner R., Wessner B., Strasser E., and Spittler A. Regulative potential of glutamine-relation to glutathione metabolism. Nutrition 18 3 (2002) 217-221
49. Salako M.A., Carter M.J., and Kass G.E. Coxsackievirus protein 2BC blocks host cell apoptosis by inhibiting caspase-3. J. Biol. Chem. (2006)
50. Schenk H., Klein M., Erdbrugger W., Droge W., and Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc. Natl. Acad. Sci. U.S.A. 91 5 (1994) 1672-1676
51. Sherry B., and Rueckert R. Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J. Virol. 53 1 (1985) 137-143
52. Solano-Aguilar G.I., Zarlenga D., Beshah E., Vengroski K., Gasbarre L., Junker D., Cochran M., Weston C., Valencia D., Chiang C., Dawson H., Urban J.F., and Lunney J.K. Limited effect of recombinant porcine interleukin-12 on porcine lymphocytes due to a low level of IL-12 beta2 receptor. Vet. Immunol. Immunopathol. 89 3-4 (2002) 133-148
53. Staal F.J. Glutathione and HIV infection: reduced reduced, or increased oxidized?. Eur. J. Clin. Invest. 28 3 (1998) 194-196
54. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27 3 (1969) 502-522
55. Tolskaya E.A., Romanova L.I., Kolesnikova M.S., Ivannikova T.A., Smirnova E.A., Raikhlin N.T., and Agol V.I. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J. Virol. 69 2 (1995) 1181-1189
56. Uhlig S., and Wendel A. The physiological consequences of glutathione variations. Life Sci. 51 14 (1992) 1083-1094
57. van der Ven A.J., Blom H.J., Peters W., Jacobs L.E., Verver T.J., Koopmans P.P., Demacker P., and van der Meer J.W. Glutathione homeostasis is disturbed in CD4-positive lymphocytes of HIV-seropositive individuals. Eur. J. Clin. Invest. 28 3 (1998) 187-193
58. Vance L.M., Moscufo N., Chow M., and Heinz B.A. Poliovirus 2C region functions during encapsidation of viral RNA. J. Virol. 71 11 (1997) 8759-8765
59. Verlinden Y., Cuconati A., Wimmer E., and Rombaut B. Cell-free synthesis of poliovirus: 14S subunits are the key intermediates in the encapsidation of poliovirus RNA. J. Gen. Virol. 81 Pt. 11 (2000) 2751-2754
60. Wang Y.M., Peng S.Q., Zhou Q., Wang M.W., Yan C.H., Yang H.Y., and Wang G.Q. Depletion of intracellular glutathione mediates butenolide-induced cytotoxicity in HepG2 cells. Toxicol. Lett. 164 3 (2006) 231-238
61. Wellner V.P., Anderson M.E., Puri R.N., Jensen G.L., and Meister A. Radioprotection by glutathione ester: transport of glutathione ester into human lymphoid cells and fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 81 15 (1984) 4732-4735
62. Wimmer E., Hellen C.U., and Cao X. Genetics of poliovirus. Annu. Rev. Genet. 27 (1993) 353-436
63. Wullner U., Seyfried J., Groscurth P., Beinroth S., Winter S., Gleichmann M., Heneka M., Loschmann P., Schulz J.B., Weller M., and Klockgether T. Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res. 826 1 (1999) 53-62